William Blair Issues Negative Outlook for Danaher Earnings

Danaher Co. (NYSE:DHR) – William Blair lowered their Q1 2025 earnings per share estimates for Danaher in a research report issued on Thursday, January 30th. William Blair analyst M. Larew now forecasts that the conglomerate will post earnings per share of $1.62 for the quarter, down from their prior estimate of $2.00. The consensus estimate for Danaher’s current full-year earnings is $8.15 per share. William Blair also issued estimates for Danaher’s Q3 2025 earnings at $1.94 EPS, FY2025 earnings at $7.62 EPS and Q1 2026 earnings at $1.81 EPS.

Danaher (NYSE:DHR) last issued its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.72% and a net margin of 16.33%. During the same period in the previous year, the company posted $2.09 EPS.

Several other analysts have also issued reports on DHR. Stephens reiterated an “overweight” rating and issued a $315.00 target price on shares of Danaher in a research note on Wednesday, October 23rd. Guggenheim began coverage on shares of Danaher in a research report on Thursday, December 19th. They set a “buy” rating and a $275.00 target price on the stock. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price for the company in a report on Thursday, October 31st. JPMorgan Chase & Co. dropped their price target on Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Finally, Scotiabank started coverage on Danaher in a research note on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price objective for the company. Six analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $278.00.

Danaher Trading Down 0.2 %

Shares of Danaher stock opened at $222.56 on Monday. The company has a market capitalization of $160.75 billion, a P/E ratio of 42.15, a price-to-earnings-growth ratio of 4.22 and a beta of 0.83. The stock has a fifty day simple moving average of $235.40 and a 200 day simple moving average of $253.08. Danaher has a 12-month low of $221.34 and a 12-month high of $281.70. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32.

Institutional Trading of Danaher

Hedge funds have recently added to or reduced their stakes in the business. AMF Tjanstepension AB purchased a new stake in Danaher during the 3rd quarter valued at $5,923,000. Czech National Bank increased its holdings in Danaher by 4.2% during the 3rd quarter. Czech National Bank now owns 130,939 shares of the conglomerate’s stock valued at $36,404,000 after purchasing an additional 5,320 shares during the period. GAMMA Investing LLC raised its position in Danaher by 33.5% during the 3rd quarter. GAMMA Investing LLC now owns 4,480 shares of the conglomerate’s stock valued at $1,246,000 after purchasing an additional 1,125 shares during the last quarter. WealthBridge Capital Management LLC grew its position in shares of Danaher by 51.8% in the 3rd quarter. WealthBridge Capital Management LLC now owns 1,465 shares of the conglomerate’s stock worth $407,000 after buying an additional 500 shares during the last quarter. Finally, Diversified Trust Co increased its stake in shares of Danaher by 29.6% during the third quarter. Diversified Trust Co now owns 5,649 shares of the conglomerate’s stock valued at $1,571,000 after buying an additional 1,289 shares during the period. 79.05% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 11.10% of the company’s stock.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were given a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.49%. Danaher’s payout ratio is presently 20.45%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.